Related Experiment Videos
Prolonged pyrexia in a diabetic due to systemic aspergillosis
1Department of Medicine and Pathology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi-110029, India.
The Journal of the Association of Physicians of India
|March 7, 2001
Abstract:
Immuno-compromised patients are susceptible to a variety of opportunistic infections. Systemic aspergillosis is one such common infection in neutropenic subjects. A case of primary cutaneous aspergillosis with fungimia in a diabetic is reported.
Insights
This case report details primary cutaneous aspergillosis with fungemia in a diabetic patient, highlighting infection risks in immunocompromised individuals. It underscores the importance of recognizing invasive fungal infections in susceptible populations.
Area of Science:
- Mycology
- Infectious Diseases
- Immunocompromised Host Research
Background:
- Opportunistic infections pose significant risks to immunocompromised patients.
- Systemic aspergillosis is a prevalent concern, particularly in neutropenic individuals.
- Diabetes mellitus can further compromise immune defenses, increasing susceptibility to infections.
Observation:
- A case of primary cutaneous aspergillosis was identified.
- The patient presented with fungemia (fungal presence in the bloodstream).
- The affected individual had a history of diabetes mellitus.
Findings:
- Primary cutaneous aspergillosis can occur in diabetic patients.
- Fungemia can be a complication of cutaneous aspergillosis.
- This presentation highlights a less common but serious manifestation of Aspergillus infection.
Implications:
- Early recognition and treatment of cutaneous aspergillosis are crucial in diabetic and immunocompromised patients.
- Fungemia indicates systemic spread and requires prompt antifungal therapy.
- This case expands understanding of Aspergillus infection spectrum in vulnerable populations.